1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. My Size, Inc.
  6. News
  7. Summary
    MYSZ   US62844N2080

MY SIZE, INC.

(MYSZ)
  Report
End-of-day quote TEL AVIV STOCK EXCHANGE  -  05-21
0.7890 ILS   +0.38%
05/13My Size, Inc. Reiterates Earnings Guidance for the Year 2022
CI
05/12MY SIZE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/12My Size, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

MY SIZE, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)

01/03/2022 | 08:02am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.



As further described in Item 5.07 below, on December 30, 2021, at the 2021 annual meeting of stockholders (the "Annual Meeting") of My Size, Inc. (the "Company") the Company's stockholders approved an amendment to the My Size, Inc. 2017 Equity Incentive Plan ("2017 Plan") to increase the shares reserved for issuance under the 2017 Plan from 1,450,000 to 5,770,000 shares (the "2017 Plan Amendment"). The 2017 Plan Amendment was previously adopted by the Company's board of directors subject to stockholder approval. The 2017 Plan and the 2017 Plan Amendment are described in greater detail in the Company's definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission ("SEC") on December 6, 2021 (the "Proxy Statement"), under the caption "Approval of an Amendment to the My Size, Inc. 2017 Equity Incentive Plan to Increase the Reservation of Common Stock for Issuance Thereunder to 5,770,00 Shares From 1,450,000 Shares," which disclosure is incorporated herein by reference. The description of the 2017 Plan as amended by the 2017 Plan Amendment contained in the Proxy Statement is qualified in its entirety by reference to the full text of the 2017 Plan as amended by the 2017 Plan Amendment, which is attached as Exhibit 10.1 hereto and is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 30, 2021, the Company held its Annual Meeting for the following purposes: (1) to elect five directors, (2) to approve the Company's Stockholder Rights Plan, (3) to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to classify the board of directors into three classes with staggered three-year terms, (4) to approve an amendment to the Company's Certificate of Incorporation to increase the authorized number of shares of the Company's Common Stock from 100,000,000 shares to 250,000,000 shares, (5) to approve an amendment to the 2017 Plan to increase the reservation of common stock for issuance thereunder to 5,770,000 shares from 1,450,000 shares, and (6) to ratify the appointment of Somekh Chaikin as the Company's independent public accountant for the fiscal year ending December 31, 2021. A total of 15,988,761 shares of common stock constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. With the exception of Proposal 3, all matters submitted to a vote of the Company's stockholders at the Annual Meeting were approved and the director nominees were elected.

On November 4, 2021, the Company entered into a settlement agreement with David Lazar and certain affiliates and director nominees. A description of the settlement is included in the Proxy Statement under the caption "Certain Relationships and Related Transactions, and Director Independence - Settlement Agreement with Lazar Parties" which disclosure is incorporated herein by reference. The foregoing description does not purport to be complete and is qualified in its entirety by reference to the full text of the settlement agreement, a copy of which is attached as Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on November 5, 2021 and is incorporated herein by reference.

Set forth below are the matters acted upon by the Company's stockholders at the Annual Meeting and the final voting results on each such matter.

Proposal 1. Election of five directors to serve on the Company's board of directors until the 2022 annual meeting of stockholders or until their successors are elected and qualified:



                                                  Broker
Nominee              For          Withheld       Non-Votes
Ronen Luzon        11,850,411       627,673       3,510,675
Arik Kaufman       11,918,868       559,216       3,510,675
Oren Elmaliah      11,923,419       554,665       3,510,675
Oron Braniztky     11,922,276       555,808       3,510,675
Guy Zimmerman      11,922,109       555,975       3,510,675










Proposal 2. Approval of the Company's Stockholder Rights Plan:



                                              Broker
    For           Against      Abstain       Non-Votes
  11,804,571       579,135       94,378       3,510,675





Proposal 3. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to classify the board of directors into three classes with staggered three-years terms.

The information set forth in Item 8.01 of this Current Report is incorporated into this Item 5.07 by reference.

Proposal 4. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company's Common Stock from 100,000,000 shares to 250,000,000 shares:



                                                Broker
    For            Against       Abstain       Non-Votes
  14,373,846       1,577,290       37,623             0





Proposal 5. Approval of an amendment to the My Size 2017 Equity Incentive Plan to increase the reservation of common stock for issuance thereunder to 5,770,000 shares from 1,450,000 shares:



                                              Broker
    For           Against      Abstain       Non-Votes
  11,645,126       821,103       11,857       3,510,675





Proposal 6. Ratification of the appointment of Somekh Chaikin as the Company's independent public accountant for the fiscal year ending December 31, 2021:



                                                Broker
    For            Against       Abstain       Non-Votes
  14,868,445       1,045,986       74,330             0

Item 8.01 Other Events.

With respect to Proposal 3 regarding the amendment to the Company's Amended and Restated Certificate of Incorporation to classify the board of directors into three classes with staggered three-year terms, the Annual Meeting was adjourned to January 6, 2022, at 10:00 a.m. Eastern Time. The adjourned Annual Meeting will be held at the Offices of Barnea Jaffa Lande & Co Law Offices, located at 58 HaRakevet Street, Tel Aviv 6777016, Israel. The purpose of the adjournment is to allow additional time for the Company's stockholders to vote on Proposal 3.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits


10.1 My Size, Inc. Amendment to the My Size, Inc. 2017 Equity Plan

(incorporated by reference to Appendix D to the Company's definitive proxy

statement filed with the SEC on December 6, 2021).

104 Cover Page Interactive Data File (formatted as Inline XBRL).

© Edgar Online, source Glimpses

All news about MY SIZE, INC.
05/13My Size, Inc. Reiterates Earnings Guidance for the Year 2022
CI
05/12MY SIZE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/12My Size, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/19MY SIZE : Are brands really meeting body inclusivity goals with sizing?
PU
04/19MY SIZE : How does sizing tech tackle the challenges of fitting workwear today?
PU
04/11MY SIZE : Financial Statements - Form 8-K/A
PU
04/11MY SIZE, INC. Financial Statements and Exhibits (form 8-K/A)
AQ
03/30THE GREAT RETURN TO BRICK AND MORTAR : How to stand out amoung the crowd
PU
03/18MY SIZE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT ..
AQ
03/18My Size, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
More news
Financials (USD)
Sales 2022 2,00 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 5,95 M 5,95 M -
Capi. / Sales 2022 2,97x
EV / Sales 2023
Nbr of Employees 31
Free-Float 81,2%
Chart MY SIZE, INC.
Duration : Period :
My Size, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Ronen Luzon Chief Executive Officer & Director
Kles Or Chief Financial Officer
Eli Turchinsky Technology Director
Billy Pardo Luzon Balla Chief Operating & Product Officer
Oron Braniztky Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MY SIZE, INC.-52.41%6
SNAP INC.-50.54%38 061
KAKAO GAMES CORP.-35.27%3 574
ANGI INC.-45.60%2 517
DENA CO., LTD.11.80%1 836
MODERN TIMES GROUP MTG AB (PUBL)22.62%1 250